相关实验视频
Updated: Jun 4, 2025

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
目前治疗性结肠炎的方法:方法和治疗方法的全面概述
Aman Rawat1, Richa Srivastava1
1Amity Institute of Pharmacy, Lucknow, Amity University Uttar Pradesh, Sector 125, Noida, 201313, India.
性结肠炎是一种慢性炎症性肠病,影响结肠. 本综述探讨了它的病理生理学,遗传和环境因素,以及不断发展的治疗方法,包括新的药物类别和不同的剂量形式,以满足患者的需求.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 性结肠炎 (UC) 是结肠的慢性异常性炎症状况,是炎症性肠病的一部分.
- 病理生理学涉及遗传,环境和炎症因素,通常在30-40岁的人群中出现.
- 疾病的进展从直肠开始,然后移动到直肠附近,由反复的粘膜炎症标志着.
研究的目的:
- 提供对性结肠炎的全面了解.
- 突出目前和不断发展的UC治疗选择.
- 审查可用的剂量形式及其对患者服药遵守的影响.
主要方法:
- 性结肠炎病理生理学和管理的文献综述.
- 分析当前的治疗策略,包括生物药物和小分子.
- 检查UC治疗的各种可用的剂型.
主要成果:
- 治疗的严重程度指导了性结肠炎的治疗策略.
- 新兴疗法包括抗瘤缩因子-α单克隆抗体和Janus激酶抑制剂.
- 为了实现临床和内镜缓解,存在各种剂型 (药片,囊,假药).
结论:
- 性结肠炎的治疗正在随着新的治疗药物和药物输送系统的发展而发展.
- 优化剂型对于提高患者的服药性和治疗疗效至关重要.
- 持续的研究有望进一步改善这种慢性炎症状况的管理.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...